Angiotensin receptor

Internal medicine

Heart failure

Discontinuation

Ejection fraction

Blood pressure

Cardiology

Renin–angiotensin system

Beta blocker

Medicine

Journal of Cardiac Failure

Current practice guidelines recommend that patients with heart failure (HF) with reduced ejection fraction (HFrEF) be treated with multiple medications at target dosages derived from landmark randomized clinical trials, as tolerated.1–3 However, the use and dosing of these medications in routine practice typically falls short of levels achieved in clinical trials.4,5 As a way of improving medication use, hospitalization for HF has been championed as a key opportunity to optimize evidence-based therapy for chronic HFrEF.

Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry